isoxazoles has been researched along with Cirrhoses, Experimental Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, H; Jing, X; Wu, J; Zou, X | 1 |
| Li, J; Tang, X; Yang, J | 1 |
| Chen, JQ; Li, J; Xu, SY; Yao, HW | 1 |
3 other study(ies) available for isoxazoles and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
[Role of cyclooxygenase 2 and its inhibitor valdecoxib in liver fibrosis].
Topics: Actins; Animals; Collagen; Cyclin D1; Cyclin E; Cyclooxygenase 2; Hepatic Stellate Cells; Isoxazoles; Liver Cirrhosis, Experimental; Male; Mice; Mice, Knockout; Oncogene Proteins; Sulfonamides | 2014 |
Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis.
Topics: Adjuvants, Immunologic; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Culture Media, Conditioned; Hepatic Stellate Cells; Isoxazoles; Kupffer Cells; Leflunomide; Liver Cirrhosis, Experimental; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; TNF-Related Apoptosis-Inducing Ligand | 2009 |
Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
Topics: Adjuvants, Immunologic; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride Poisoning; Collagen Type III; Hydroxyproline; Isoxazoles; Leflunomide; Liver; Liver Cirrhosis, Experimental; Male; NF-kappa B; Nitric Oxide; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |